Insider · CIK 0001932843
David E. Lazar
Files at BGMS (Cyclacel Pharmaceuticals, Inc.), FIEE (FiEE, Inc.), ATER (Aterian, Inc.), YHC (LQR House Inc.). First filing Dec 31, 2024, latest Aug 4, 2025.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
BGMS: Cyclacel Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
FIEE: FiEE, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 21Weak | BGMSsell Cyclacel Pharmaceuticals, Inc. | $83k 6,750 shares | -4% | +274% from low-93% from high | |
| 55Moderate | BGMSsell Cyclacel Pharmaceuticals, Inc. | $5.5M 194,628,820 shares | -100% | - | |
| 32Weak | FIEEbuy FiEE, Inc. | $50k 1,456,980 shares | +5828% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | ATER Aterian, Inc. | CConversion Common Stock | +1,300,530 | $0.00 | $0 | 8,038,030 | 13 d ago |
| Sep 25, 2026 | ATER Aterian, Inc. | SOpen-market sale Series AAA Convertible Non-Redeemable Preferred Stockderivative | -1,750,000 | $6.70 | $12M | 0 | 13 d ago |
| Sep 25, 2026 | ATER Aterian, Inc. | SOpen-market sale Series AA Convertible Non-Redeemable Preferred Stockderivative | -706,100 | $0.38 | $270k | 0 | 13 d ago |
| Sep 24, 2026 | ATER Aterian, Inc. | CConversion Series AA Convertible Non-Redeemable Preferred Stockderivative | -168,900 | $0.00 | $0 | 706,100 | 13 d ago |
| Aug 4, 2026 | ATER Aterian, Inc. | CConversion Common Stock | +875,000 | $2.00 | $1.8M | 6,737,500 | 31 d ago |
| Jul 17, 2026 | ATER Aterian, Inc. | AGrant or award Series AAA Convertible Non-Redeemable Preferred Stockderivative | +1,750,000 | $2.00 | $3.5M | 1,750,000 | 31 d ago |
| Aug 4, 2026 | ATER Aterian, Inc. | CConversion Series AA Convertible Non-Redeemable Preferred Stockderivative | -875,000 | $0.00 | $0 | 6,737,500 | 31 d ago |
| Jul 30, 2025 | BGMS Cyclacel Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -6,750 | $12.36 | $83k | 155,838 | Aug 4, 2025 |
| Apr 2, 2025 | YHC LQR House Inc. | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 100,000 | Apr 7, 2025 |
| Feb 18, 2025 | FIEE FiEE, Inc. | AGrant or award Common Stock | +1,200,000 | - | - | 2,681,980 | Mar 10, 2025 |
| Feb 18, 2025 | FIEE FiEE, Inc. | SOpen-market sale Series A Convertible Preferred Stockderivative | -2,219,447 | - | - | 85,910 | Mar 10, 2025 |
| Feb 18, 2025 | FIEE FiEE, Inc. | SOpen-market sale Warrantsderivative | -2,800,000 | - | - | 0 | Mar 10, 2025 |
| Feb 26, 2025 | BGMS Cyclacel Pharmaceuticals, Inc. | MOption exercise Common Stock | +2,650,000 | - | - | 2,650,000 | Feb 28, 2025 |
| Feb 26, 2025 | BGMS Cyclacel Pharmaceuticals, Inc. | MOption exercise Common Stock | +191,978,820 | - | - | 194,628,820 | Feb 28, 2025 |
| Feb 26, 2025 | BGMS Cyclacel Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -194,628,820 | $0.03 | $5.5M | 0 | Feb 28, 2025 |
| Feb 26, 2025 | BGMS Cyclacel Pharmaceuticals, Inc. | MOption exercise Series C Convertible Preferred Stockderivative | -1,000,000 | - | - | 0 | Feb 28, 2025 |
| Feb 26, 2025 | BGMS Cyclacel Pharmaceuticals, Inc. | MOption exercise Series D Convertible Preferred Stockderivative | -1,745,262 | - | - | 354,738 | Feb 28, 2025 |
| Feb 6, 2025 | BGMS Cyclacel Pharmaceuticals, Inc. | AGrant or award Series D Convertible Preferred Stockderivative | +2,100,000 | - | - | 2,100,000 | Feb 10, 2025 |
| Dec 26, 2024 | FIEE FiEE, Inc. | POpen-market purchase Common Stock | +1,456,980 | $0.03 | $50k | 1,481,980 | Dec 31, 2024 |
| Nov 21, 2024 | YHC LQR House Inc. | SOpen-market sale Common Stock | -821,818 | - | - | 280,000 | Nov 25, 2024 |
| Nov 25, 2024 | YHC LQR House Inc. | SOpen-market sale Common Stock | -280,000 | - | - | 0 | Nov 25, 2024 |
| Oct 21, 2024 | FIEE FiEE, Inc. | AGrant or award Series A Convertible Preferred Stockderivative | +305,357 | - | - | 2,305,357 | Oct 22, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.